Russell Investments Group Ltd. Has $13.09 Million Stock Position in STERIS plc (NYSE:STE)

Russell Investments Group Ltd. decreased its stake in STERIS plc (NYSE:STE - Free Report) by 4.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 63,691 shares of the medical equipment provider's stock after selling 3,285 shares during the quarter. Russell Investments Group Ltd. owned 0.06% of STERIS worth $13,089,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Aviva PLC raised its position in shares of STERIS by 55.1% in the 4th quarter. Aviva PLC now owns 84,672 shares of the medical equipment provider's stock valued at $17,405,000 after acquiring an additional 30,064 shares during the period. Wells Fargo & Company MN raised its holdings in STERIS by 0.4% in the fourth quarter. Wells Fargo & Company MN now owns 88,360 shares of the medical equipment provider's stock worth $18,163,000 after purchasing an additional 394 shares during the period. Cynosure Group LLC bought a new position in shares of STERIS during the fourth quarter worth $279,000. Geode Capital Management LLC boosted its position in shares of STERIS by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 2,359,748 shares of the medical equipment provider's stock worth $483,775,000 after purchasing an additional 56,123 shares in the last quarter. Finally, National Bank of Canada FI grew its holdings in shares of STERIS by 16.3% in the 4th quarter. National Bank of Canada FI now owns 46,221 shares of the medical equipment provider's stock valued at $9,501,000 after buying an additional 6,486 shares during the period. Institutional investors own 94.69% of the company's stock.

Remove Ads

Analyst Ratings Changes

STE has been the topic of several recent analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Monday, April 7th. Stephens reaffirmed an "overweight" rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. Finally, Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, STERIS has an average rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Stock Down 1.4 %

Shares of NYSE:STE traded down $3.22 during mid-day trading on Tuesday, reaching $220.79. 153,744 shares of the stock were exchanged, compared to its average volume of 533,206. The stock's 50 day simple moving average is $222.67 and its 200-day simple moving average is $219.40. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The company has a market cap of $21.69 billion, a P/E ratio of 46.88 and a beta of 0.87. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.03%. STERIS's dividend payout ratio (DPR) is presently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.